Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and Company (NYSE:LLY) said that it would increase the list price of its diabetes and weight-loss drug Mounjaro in the UK,

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down prices in the United States after weeks of pressure from the Trump administration.

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be unaffected.